Acute exacerbation of superinfected EPOC in elderly patients with multiple comorbidities
DOI:
https://doi.org/10.62059/LatArXiv.preprints.649Keywords:
UGA, COPD, Mucolytics, Bronchodilators, AntibioticsAbstract
Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory condition with high prevalence and significant mortality. It predominantly affects older adults with multiple comorbidities. Acute exacerbations, usually of infectious origin, represent a major cause of hospitalization and functional decline. Methods: We report the case of an 80-year-old male patient with a history of COPD, chronic ischemic heart disease, arterial hypertension, and former smoker, who was admitted to the Dr. Bolívar Argüello Geriatric Hospital due to progressive dyspnea, productive cough, and oxygen desaturation. A comprehensive clinical assessment was performed, including laboratory tests, arterial blood gas analysis, serial electrocardiograms, and chest radiography. Discusión: Findings revealed hypoxemia, elevated C-reactive protein levels, secondary polycythemia, mild thrombocytopenia, and urinalysis compatible with urinary tract infection. Chest radiography showed pulmonary hyperinflation and increased bronchovascular markings. Electrocardiograms demonstrated conduction abnormalities suggestive of trifascicular block. Based on these findings, a diagnosis of acute infective exacerbation of COPD was established. The patient was treated with broad-spectrum antibiotics, inhaled bronchodilators, mucolytics, oxygen therapy, and prophylactic anticoagulation, achieving a favorable clinical outcome. Conclusion: Acute exacerbations of COPD in geriatric patients with multiple comorbidities require a comprehensive and multidisciplinary approach. Timely management allowed clinical stabilization and contributed to a favorable outcome during the current acute hospitalization.
References
Lopez-Campos, J. L., Almagro, P., Gómez, J. T., Chiner, E., Palacios, L., Hernández, C., ... & Miravitlles, M. (2022). Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos. Archivos de Bronconeumología, 58(4), 334-344.
Miravitlles, M., Calle, M., Molina, J., Almagro, P., Gómez, J. T., Trigueros, J. A., ... & Soler-Cataluna, J. J. (2022). Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable. Arch Bronconeumol, 58(1), 69-81.
Fernández, F. A. V., Torres, A. A. G., & Villegas, J. A. C. (2022). Enfermedad pulmonar obstructiva crónica (EPOC). RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, 6(3), 94-102.
Barrueco-Otero, E., Matellán, B. R., Puente, J. M., Mañes, C. V., Subias, E. L., Pueyo, J. O., & Sanchez, C. S. (2022). Prevalencia de síntomas depresivos y diagnóstico de sospecha de depresión en pacientes con EPOC. Atención primaria, 54(3), 102236.
Castillo, E. G., Vargas, G., Guerra, J. A. G., López-Giraldo, A., & Pérez, T. A. (2022). Enfermedad pulmonar obstructiva crónica. Open Respiratory Archives, 4(2), 100171.
Downloads
Downloads
Posted
Categories
Data Availability Statement
Los datos anonimizados que sustentan los hallazgos del presente caso clínico estarán disponibles previa solicitud al autor correspondiente, conforme al consentimiento informado otorgado por el paciente.License
Copyright (c) 2026 Aarón Tubón (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This preprint contains the reported license and associated copyright. Once published in an associated journal or other publisher, the published version assumes the publisher's terms and conditions.
